Article 29 Jul 2025 FDA Begins To Accept Nominations For The Commissioner's National Priority Voucher Pilot Program United States Healthcare
Article 29 Jul 2025 Critical Medical Device Series: Part VI Navigating Innovation: The FDA's Role In Regulating Medical Technology (Video) United States Healthcare
Article 25 Jul 2025 AI-llowed Or Infringing? Are AI Research Tools Protected Under The Safe Harbor? United States Healthcare
Article 23 Jun 2025 FDA Announces Commissioner's National Priority Vouchers To Facilitate Expedited Access To Certain Drugs United States Healthcare
Article 02 Jun 2025 AI, Medical Products & FDA, Part 1: AI Overview In Life Sciences (Podcast) United States Healthcare
Article 16 Jan 2025 FDA Finalizes Its SIUU Guidance: An Analysis Of The Key Changes From The 2023 Draft Guidance United States Healthcare
Article 17 Dec 2024 FDA Issues New Draft Guidance For Expedited Program For Serious Conditions — Accelerated Approval Of Drugs And Biologics United States Healthcare
Article 15 Jul 2024 FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs United States Healthcare
Article 03 Jul 2024 Chevron Overturned: What Does It Mean For Life Sciences Companies? United States Healthcare
Article 27 May 2024 Federal Circuit Overrules Rosen-Durling Standard For Design Patents United States IP
Article 20 May 2024 What You Should Know About The FDA's New Final Rule On LDTs United States Healthcare
Article 13 May 2024 FDA Intends To Regulate Many Clinical Labs As Medical Device Manufacturers: What You Need To Know About The Laboratory Developed Test Final Rule United States Healthcare
Article 08 May 2024 Five Key Takeaways From FDA's Updated Draft Guidance On Biosimilars Promotion United States Healthcare